Table 4. Associations of changes in monocytes subsets, ILC2s, and β2AR expression within Mo subsets with anthropometric and metabolic features after dietary restriction.
Dependent variable | Regressors | β±S.E. | T | p-level |
---|---|---|---|---|
ΔNon-Classical monocytes (NCM; CD14-CD16++). Adjusted R2 = 0.94 | ||||
Intercept | -4.07 | <0.00013 | ||
ΔLeptin levels | -0.27±0.12 | -2.22 | <0.03 | |
ΔHDL-C | -0.24±0.12 | -1.96 | <0.046 | |
ΔIntermediate monocytes (IM; CD14+CD16+) Adjusted R2 = 0.134 | ||||
Intercept | 2.25 | <0.04 | ||
ΔLeptin levels | -0.34±0.12 | -2.91 | <0.01 | |
ΔHDL-C | -0,24±0.12 | -2.02 | <0.047 | |
ΔClassical monocytes (CM; CD14+CD16-) Adjusted R2 = 0.157 | ||||
Intercept | 3.79 | <0.0001 | ||
ΔHDL-cholesterol | 0.37±0.11 | 3.20 | <0.002 | |
ΔCD16+/CD16- ratio Adjusted R2 = 0.316 | ||||
Intercept | -4.49 | <0.00003 | ||
ΔHDL-Cholesterol | -0.34±0.10 | -3.29 | <0.0017 | |
ΔLeptin | -0.31±0.11 | -2.82 | <0.0065 | |
ΔBMI | -0.32±0.11 | -2.82 | <0.0065 | |
ΔREE | 0.23±0.11 | 2.08 | <0.04 | |
ΔGroup 2 innate lymphoid cells (ILC2s) Adjusted R2 = 0.143 | ||||
Intercept | 7.37 | <0.0000001 | ||
ΔHOMA-IR | -0.40±0.12 | -3.42 | <0.0011 | |
Δβ2AR expression on NCM Adjusted R2 = 0.401 | ||||
Intercept | -5.04 | <0.000005 | ||
ΔBMI | -0.53±0.10 | -5.12 | <0.000003 | |
ΔLeptin | 0.49±0.11 | 4.66 | <0.000018 | |
ΔHDL-C | 0.25±0.10 | 2.63 | <0.011 | |
ΔHOMA-IR | -0.24±0.10 | -2.37 | <0.021 | |
Δβ2AR expression on IM Adjusted R2 = 0.058 | ||||
Intercept | -3.09 | <0.0030 | ||
ΔBMI | -0.27±0.12 | -2.22 | <0.029 | |
Δβ2AR expression on CM Adjusted R2 = 0.258 | ||||
Intercept | -4.54 | <0.000026 | ||
ΔBMI | -0.53±0.11 | -4.65 | <0.000018 | |
ΔLeptin | 0.25±0.11 | 2.19 | <0.032 |
The associations were evaluate by multiple regression (n = 52). p<0.05 was considered statistically significant.
Δ, delta; BMI, body mass index; REE, energy expenditure; β2AR, beta-2 adrenergic receptor; NCM, non-classical monocytes (CD14-CD16++); IM, intermediate monocytes (CD14+CD16+); CM, classical monocytes (CD14+CD16+).